EUCTR2019-003698-24-NL进行中（未招募）1 期
Patient preference-based phosphate binder therapy in haemodialysis patients: a feasibility study on patient satisfaction - Triple-P
Amsterdam UMC, location VUmc0 个研究点目标入组 40 人开始时间: 2021年4月12日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age = 18 years
- •-Haemodialysis patients (since at least 3 months)
- •-Necessity of phosphate binding therapy
- •-Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •-Intolerance to one of three types of phosphate binders
- •-Expected cessation of dialysis treatment within six months
研究者
相似试验
招募中
4 期
Patient preference-based phosphate binder therapy in haemodialysis patients: a feasibility study on patient satisfactiochronic kidney diseaseNL-OMON55060Amsterdam UMC40
尚未招募
不适用
Patient preference based phosphate binder therapyNL-OMON25073Amsterdam UMC, location VUmc40
已完成
不适用
Efficacy and safety of phosphate binders in patients on hemodialysisPatients undergoing maintenance hemodialysisJPRN-UMIN000031733ihon University School of Medicine60
已完成
不适用
Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)JPRN-UMIN000021555Asahikawa Medical University10
已完成
不适用
Patient preference for monthly bisphosphonate versus weekly bisphosphonate in a cluster-randomized, open-label, crossover trialJPRN-UMIN000024211Clinical practice-based osteoporosis conference140